WASHINGTON (NEXSTAR) – The Department of Veterans Affairs is studying how psychedelic-assisted therapy could help veterans with post-traumatic stress disorder.
“We have over 12 studies going on right now within the VA that deal with psychedelics, MDMA, psilocybin and others, and we’re continuing to push forward on that,” VA Secretary Doug Collins said.
Collins says he wants to make sure all options are on the table when it comes to taking care of those who served.
“We’re already seeing some great results. And that’s what’s kept us to push for more as we go forward,” Collins said.
Last year, the FDA rejected a psychedelic treatment for PTSD, saying the data wasn’t there. Now, some lawmakers say they’re optimistic the tide is turning with the administration conducting research.
“Sure smells like we’re heading in the right direction. It feels like it,” Rep. Lou Correa (D-Calif.) said.
California Democratic Congressman Lou Correa chairs a caucus to promote studying psychedelic therapies, and says he’s had encouraging meetings with Secretary Collins. He sees this as a potential way to stem veteran suicides.
“I want some solutions. Twenty or so veteran suicides a day because of PTSD is way too many. One is too, many let alone 20,” Correa said.
Correa says he also wants to make sure people aren’t leaving the U.S. to get treatment.
“Do they go to somebody who’s credible? Do they go to somebody who knows what they’re doing?” Correa asked.
The FDA in 2017 designated MDMA, also known as ecstasy, as a “breakthrough therapy” indicating it could be more helpful than existing treatments.